This year-end recap highlights how clinical care, research, education, and community partnerships create impact, while evolving together as one health system to serve our region now and into the future.
A microbe called Turicibacter improves metabolic health and reduces weight gain in mice. The results could lead to new ways to control weight by adjusting gut bacteria.
For half a century, the University of Utah’s Anticonvulsant Drug Development (ADD) Program has been at the forefront of discovery, helping millions of people living with epilepsy and seizure disorders.
A new kind of antibiotic delivery system, developed through U of U Health research, helps dogs, cats, and horses recover from tough-to-treat infections--and may soon help humans heal as well.
As the funding climate for research becomes less certain, it is increasingly important to find alternative sources of support so that novel ideas don’t become lost opportunities. We’re proud to...
University of Utah Health surpassed the half-billion–dollar mark in research funding for FY2025. These investments fuel research, advance knowledge, improve health, and support training of future scientific leaders.
Check out a variety of funding opportunities across issuing agencies that include an ARPA-H opportunity for Functional Repair of Neocortical Tissue (FRONT), breast cancer research, addressing rare diseases, and more.
Funding opportunities are available across a variety of topics and specialties, ranging from Transformative Research Awards, New Innovator Award Programs, to rare clinical disease research.
Research in the Sundquist lab laid the foundations for the development of lenacapavir, a drug that prevents HIV infection with 99.9% to 100% efficacy and could dramatically lower infection rates...
